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ABSTRACT 
Background: Although cardiac-related mortality 
rates are declining for the general population in 
the United States, this is not the case for pa-
tients with diabetes. Diabetes is a significant 
independent predictor of atrial fibrillation (AF), 
the most common cardiac rhythm disturbance 
responsible for substantial morbidity and mortality. 
Objectives: This research was designed to 
evaluate properties of the atrial tissue between 
patients with and without type 2 diabetes. Heart 
rate variability (HRV) indices were calculated 
and expression of Kv1.5, connexin 43 (Cx43), 
and 40 (Cx40) were compared. Methods: Pa-
tients undergoing a CABG were enrolled: 10 
with type 2 diabetes and 8 without diabetes, 
paired for age, gender and co-morbidities such 
as hypertension and dyslipidemia. All patients 
showed normal ejection fraction. A sample of 
right auricular appendix was taken during CABG 
and Kv1.5, Cx40 and Cx43 protein contents were 
determined by western blotting and normalized 
to  α-tubulin level. Results: No HRV difference 
was found between patients with and without 
diabetes. Cx43 and Kv1.5 levels were unaffected 
by diabetes (p=0.20 and 0.07, respectively) whe- 
reas Cx40 content was significantly increased 
by 55% (p=0.02). Levels of Cx43 phosphorylated 
and non-phosphorylated forms were non-sig-
nificantly decreased in patients with diabetes. 
Conclusion: Patients with type 2 diabetes had 
higher expression of Cx40 in the right auricular 
appendix tissue. In light of other studies having 
demonstrated a link between AF and Cx40 ex-
pression, it is possible that higher prevalence of 
AF in patients with diabetes is explained, at least 
partially, by differential expression of gap-junc-
tion proteins. 
Keywords: Diabetes; Gap Junctions; Atrial Tissue; 
Atrial Fibrillation 
1. INTRODUCTION 
The prevalence of diabetes is steadily increasing in west- 
ernized societies as well as in developing countries. Al-
though the overall cardiac-related mortality rate has been 
declining for the general population in the United States, 
this is not the case for patients with diabetes [1]. Of par-
ticular significance, diabetes is a risk factor for different 
heart-related conditions such as coronary artery disease, 
heart failure, aortic stenosis and arrhythmias [2]. 
Atrial fibrillation (AF) is the most common arrhyth-
mia and is responsible for substantial morbidity and 
mortality [3]. In the Framingham study, systemic hyper-
tension and diabetes were found to be independent pre-
dictors of AF [4]. For men and women, respectively, 
diabetes increased by 1.4 and 1.6 fold the risk of devel-
oping AF. The risk of developing AF correlates with 
atrial dilatation, and the presence of left ventricular dia-
stolic dysfunction [5]. Since AF occurs as an ongoing 
process over time, subtle atrial abnormalities may pre-
cede overt atrial dilatation and contractile dysfunction 
[5-7]. These could be linked to alterations in electro-
physiological properties predisposing to AF. 
In animal models (mostly streptozotocin-induced dia-
betes models), diabetes mellitus is responsible for car-
diac arrhythmias, probably caused by an excessive 
lengthening of the cardiac action potential [8]. Several 
changes in ionic currents have been described in car-
diomyocytes isolated from animal models of diabetes, 
principally a decrease in the transient repolarizing potas-
sium current Ito [8,9]. This effect could possibly be par-
tially mediated by impaired sympathetic nervous system 
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activity [10] or by oxidative stress-induced alteration in 
the glutathione redox state [11]. 
It should be pointed out that a reduction in Vmax, [12] 
the maximum speed of the rising phase of the action 
potential, and a prolongation of the QRS complex [13, 
14] have been associated with diabetes. Changes in the 
intercellular electrical coupling through gap junctions 
could be involved in this effect. Indeed, it was demon-
strated that elevated glucose concentrations inhibit gap 
junction intercellular communication and reduced con-
nexin (Cx) expression in a variety of cells including 
vascular smooth muscle cells, endothelial cells, and 
retinal microvessels. It has been proposed that high glu-
cose concentration interfered with gap junction through 
the activation of protein kinase C [15-18]. In addition, it 
has been reported in rat model of diabetes that a 
down-regulation of Cx43 occurred and is associated with 
a compensatory over-expression of other Cxs [19,20]. 
However, direct alteration of gap junctions by diabetes 
were never assessed in human cardiomyocytes.   
The purpose of this study was to evaluate properties 
of the atrial tissue between patients with and without 
type 2 diabetes. Heart rate variability (HRV) indices 
were calculated to evaluate the potential influence of the 
cardiac autonomic nervous system. Expression levels of 
Kv1.5 (underlying IKur), connexin 43 (Cx43), and 40 
(Cx40) were compared between patients with and with-
out type 2 diabetes. 
2. RESEARCH DESIGN AND METHODS 
2.1. Study Design 
Ten subjects with type 2 diabetes and 8 subjects without 
diabetes undergoing a coronary artery bypass grafting 
surgery (CABG) were enrolled in this study. Patients in 
sinus rhythm aged between 35 and 70 were included. 
Patients with and without type 2 diabetes were paired for 
age, gender, co-morbidities such as hypertension and 
dyslipidemia. All patients had to show normal ejection 
fraction. Exclusion criteria were: 1) previous history of 
supraventricular arrhythmia, 2) significant hepatic or 
renal dysfunction (creatinine >150 mmol/L), 3) signifi-
cant pulmonary or thyroid disease, 4) any connective 
tissue disease or history of malignancy, 5) episode of 
recent heart failure, 6) acute coronary syndrome within 
the last 3 months and, 7) smoking within the previous 3 
months. The present study was approved by the local 
ethical committee of Laval Hospital. 
A sample of right auricular appendix was taken at the 
beginning of the CABG procedure, and immediately 
placed in an oxygenated Tyrode solution (in mM: NaCl 
137, KCl 5.4, CaCl2 1.8, MgCl2 1, NaHCO3 12, 
NaH2PO4 0.4, glucose 5.6) at 4℃. The tissue was sub-
sequently immersed in liquid nitrogen and stored at -80
℃ for  western  analyses. 
2.2. Heart Rate Variability 
Heart rate variability (HRV) was derived from a 24-hour 
Holter monitoring system (Marquette Electronics Inc., 
Milwaukee, WI) in all subjects during normal daily life 
activity. HRV derived from 24-hour ambulatory moni-
toring is reproducible and free of placebo effect [21]. 
Using frequency domains, power in the low frequency 
(LF, 0.04-0.15 Hz) that is an index of both sympathetic 
and parasympathetic activity, and high frequency (HF, 
0.15-0.4 Hz) that is an index of solely parasympathetic 
activity, were calculated. LF/HF ratio is the power in 
low frequency divided by the power in high frequency. 
Using time domains, the standard deviation of the RR 
intervals (SDNN), the square root of the mean squared 
differences of successive RR intervals (rMSSD) and the 
standard deviation of the average RR intervals calculated 
over 5-min periods (SDANN) were determined. pNN50 
is the proportion of interval differences of successive 
NN intervals greater than 50 ms. NN intervals are the 
normal-to-normal intervals that include all intervals be-
tween adjacent QRS complexes resulting from sinus 
node depolarizations in the entire 24-hour ECG re-
cording as previously reported [7]. 
2.3. Protein Isolation and Western Blot 
Analysis [22,23] 
Total protein content was determined with bovine serum 
albumin as standard and subsequently separated with an 
8% denaturing-PAGE. Proteins transferred to Immobilon 
PVDF membranes were incubated with antibodies for 
Kv1.5 [Alomone Labs], Cx40 [Chemicon Int.] (poly-
clonal, raised in rabbit) and Cx43 [Chemicon Int.] 
(monoclonal, mouse). Epitopes are residues 513-602 of 
mouse Kv1.5, gap junction alpha-5 protein of mouse 
connexin 40 [CxA-5], and residues 252-270 of native 
sequence from rat cardiac connexin 43, respectively. All 
primary antibodies specific for these 3 proteins were 
diluted in TBS-Tween 1:200. Membranes were respec-
tively incubated with secondary antibodies (1:10000 and 
1:5000, anti-rabbit [Cedarlane]; 1:100000, anti-mouse 
[Chemicon Int.]), conjugated with peroxidase. An ECL 
detection kit [Millipore] was used to reveal the anti-
gen-antibody for subsequent densitometric analysis. 
Kv1.5, Cx43 and Cx40 protein levels were normalized to 
α-tubulin level (1:250, polyclonal, raised in rabbit, Ab-
cam). 
2.4. Statistical Analysis 
Patient characteristics, Holter and blood chemistry pa-
rameters are reported as mean ± standard deviation 
unless otherwise specified (S.D.). Densitometry values 
are expressed as mean ± S.E.M. Comparisons between P. Daleau et al. / HEALTH 2 (2010) 271-277 
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groups were performed using an unpaired Student’s 
t-test and a p value<0.05 was considered significant.  
3. RESULTS 
There was no difference in age, body mass index (BMI) 
and left ventricular ejection fraction between groups 
(Table 1). As expected, fasting glucose level was sig-
nificantly higher in patients with diabetes (Table 1). 
There were no differences in the lipid profile between 
groups. Also, drug regimen was comparable between 
groups except for the use of hypoglycaemic agents in 
patients with diabetes (Table 2). Results from the 
24-hour Holter analysis, showed no significant differ-
ence in the indices assessed (LF, HF, LF/HF ratio, 
SDANN, rMSSD, pNN50, mean NN, SDNN) between 
patients with and without diabetes. 
Densitometric analysis showed that Cx43 levels 
(normalized with α-tubulin and tested in triplicate) were 
unaffected by diabetes (Figure 1, p = 0.20). When com-
pared to control subjects, patients with diabetes had a 
tendency of having higher expression of Kv1.5 (Figure 
3, p=0.07), whereas Cx40 content was significantly in-
creased by 55% (Figure 2, p=0.02). We also assessed 
expression levels of phosphorylated forms of Cx43. In 
patients with diabetes, expression levels of the two 
phosphoisoforms of Cx43 (P2 and P1) were decreased to 
71% and 64% of control values respectively. The  
non-phosphorylated form of Cx43 (P0) decreased to 
79% of control values. However, these differences were 
 
 
Figure 1. Representative Western blots of right auricular ap-
pendix Cx43 protein level. P0 represents the nonphosphory-
lated form, while P1 and P2 represent two phosphoisophorms 
of Cx43. The lower panel shows densitometry of Cx43 nor-
malized to α-tubulin (expressed as % of tubulin densitometry) 
in diabetes and control patients (one Control was lacking due 
to limited tissue availability). Data are means ± s.e.m. 
 
Figure 2. Representative Western blots of right auricu-
lar appendix Cx40 protein level. The lower panel shows 
densitometry of Cx40 normalized to α-tubulin (ex-
pressed as % of tubulin densitometry) in diabetes and 
control patients. Data are means ± s.e.m.; * P＜  0.05. 
 
 
Figure 3. Representative Western blots of right auricular 
appendix Kv1.5 protein level. For tubulin, only the lower 
band was considered for densitometric analysis; the upper 
band was due to a non-specific binding of the Kv1.5 anti-
body. The lower panel shows densitometry of Kv1.5 nor-
malized to α-tubulin (expressed as % of tubulin densitometry) 
in diabetes and control patients. Data are means ± s.e.m. 
 
not significant for all isoforms (p = 0.46, 0.21 and 0.23 
respectively for P0, P1 and P2). 
Among patients with diabetes, 50% (5/10) developed 
new onset of postoperative AF significant enough (epi-
sodes longer than 2h or recurrent episodes of AF) to 
require pharmacological treatment compared to 25% 
(2/8) in the control group (p = 0.27). P. Daleau et al. / HEALTH 2 (2010) 271-277 
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Table 1. Patient characteristics. 
  Diabetes 
(n=10) 
Controls 
(n=8) 
P 
value 
Age (years) 
BMI (kg/m
2) 
EF (%) 
Men/Women 
61.5 ± 13.1 
34.1 ± 7.5 
57.3 ± 7.1 
7/3 
68.4 ± 6.7 
29.5 ± 4.4 
63.4 ± 8.7 
7/1 
0.197 
0.198 
0.065 
0.815 
Blood analysis: 
Glucose (mmol/L) 
HbA1c (%) 
Apo B (g/L) 
      
7.2 ± 1.6 
7.1 ± 1.0 
0.71 ± 0.18 
 
5.2 ± 0.6 
- 
0.86 ± 0.21 
 
0.003 
- 
0.148 
Lipid profile: 
Total cholesterol (mmol/L) 
Triglycerides (mmol/L) 
HDL cholesterol (mmol/L) 
LDL cholesterol (mmol/L) 
Total-C/HDL-C 
 
3.54 ± 0.62 
1.72 ± 0.87 
1.11 ± 0.14 
1.65 ± 0.48 
3.20 ± 0.58 
 
4.04 ± 0.81 
1.82 ± 0.99 
1.18 ± 0.27 
2.03 ± 0.50 
3.57 ± 1.08 
 
0.160 
0.756 
0.657 
0.120 
0.372 
BMI = Body mass index; EF = Ejection fraction 
 
Table 2. Co-morbidities and drug regimen in both groups. 
 
Diabetes 
% (n) 
(n=10) 
Controls 
% (n) 
(n=8) 
P value 
History 
Hypertension 
Dyslipidemia 
Smoking 
 
70 (7) 
70 (7) 
10 (1) 
 
62.5 (5) 
75 (6) 
37.5 (3) 
 
0.107 
1.000 
1.000 
Rx Classes 
Nitroglycerin 
β-blockers 
CCB 
ACEI 
ARB 
α1 inhibitors 
ASA 
Diuretics 
Statins 
Fibrates 
Oral hypoglycemic agents 
Benzodiazepine 
Antidepressants 
 
40 (4) 
90 (9) 
50 (5) 
30 (3) 
60 (6) 
10 (1) 
90 (9) 
40 (4) 
90 (9) 
- 
100 (10) 
10 (1) 
10 (1) 
 
50 (4) 
87.5 (7) 
50 (4) 
- 
12.5 (1) 
12.5 (1) 
87.5 (7) 
- 
62.5 (5) 
12.5 (1) 
- 
25 (2) 
- 
 
0.143 
1.000 
1.000 
- 
1.000 
1.000 
0.125 
- 
0.375 
- 
- 
1.000 
- 
 
4. DISCUSSION 
This study assessed the effects of type 2 diabetes on the 
expressions of connexins and Kv1.5 in the human heart. 
The most important finding of this work is that patients 
with type 2 diabetes had significantly higher expression 
of Cx40 in the right auricular appendix tissue. Apart 
from the diabetic status, the 2 groups were well matched 
in terms of age and risk factors, implying that the ob-
served modulation of connexin is likely to reflect the 
effect of diabetes per se. 
4.1. Expression of Connexins and   
Modulation by Diabetes 
Assessment of protein content revealed that when com-
pared to control patients, the level of Cx40 in the right 
auricular appendix specimens was increased by 55 % in 
individuals having type 2 diabetes. Similarly, a recent 
study in rats with streptozotocin-induced diabetes has 
shown that expression of Cx40 was increased in retinal 
microvessels [18]. Although not statistically significant, 
we also observed a trend toward a decreased expression 
of Cx43 in the right auricular appendix tissues of pa-P. Daleau et al. / HEALTH 2 (2010) 271-277 
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tients with type 2 diabetes. All isoforms of Cx43 (the 
two phosphoisoforms and the non-phosphorylated form), 
were diminished, although non-significantly. It should 
be emphasized that in diabetic animal models a reduc-
tion in the expression of Cx43 has been documented in 
several tissues [17,24,25], including the heart [18,26], 
though exceptions also exist [27,28]. 
In one study, while a down-regulation of Cx43 was 
demonstrated in retinal microvessels of diabetic rats, an 
over-expression of Cx40 and Cx45 were found [18]. 
Thus, it seems possible that a down-regulation of one 
type of connexin is offset by the increased production of 
another type of gap junction protein. In the same line, a 
recent study analyzing the expression of connexins in the 
bladder of diabetic rat reported a lower amount of Cx43 
isoform and higher expression of Cx32 and 26 [17]. 
However, it has been stressed that the function of one 
type of connexin cannot necessarily be restored by the 
presence of another but different member of the con-
nexin family [29]. Hence, this ‘replacement’ hypothesis 
certainly deserves more investigations. 
4.2. Atrial Fibrillation, Connexins and K
+ 
Channels 
Diabetes has been reported as a strong and independent 
risk factor for the development of AF [30,31]. Of note, 
episodes of postoperative AF have been associated to a 
higher expression Cx40 in the right auricular appendix 
obtained from patients undergoing cardiac surgery [32, 
33,34,35]. It is likely that the relative abundance of Cx43 
and Cx40 plays an important role in the atrial impulse 
propagation, and whereby dominance of Cx40 decreases 
local propagation velocity [36]. Therefore, the modula-
tion of Cx40 expression by the diabetic environment 
could lead to micro-heterogeneities of electrical conduc-
tion pattern, promoting by this way episodes of AF. 
In different studies with experimental animal models, the 
activity of several cardiac potassium currents, such as Ito, IK 
and Iss, are modulated by diabetes and are possibly involved 
in the development and/or maintenance of AF [37,38,39]. 
However, the present results in human right auricular ap-
pendix tissue show that Kv1.5 expression remains un-
changed in patients with diabetes, suggesting that IKur is not 
affected. Nevertheless, one cannot exclude a direct modula-
tion of this current by glucose and/or insulin levels. 
4.3. Clinical Implications 
AF is the most frequent arrhythmia and has been linked 
to aging as well as to diabetes. While atrial remodeling 
is undoubtedly an important process participating to the 
development and the maintenance of AF, an electro-
physiological substrate is actively involved in the genera-
tion of arrhythmia. In this regard, the dispersion of atrial 
refractoriness and the ensuing development of multiple 
reentry wavelets are likely to be important underlying 
mechanisms pertaining to AF. In this study, the finding of 
a significant modulation of Cx40 in patients with diabetes 
may partly explain the well-documented association be-
tween diabetes and AF. By which mechanism diabetes 
contributes to increase Cx40 expression in atrial tissue is 
still unknown, but it is possible that inflammatory and/or 
oxidative stress pathways [40, 41], which are incidentally 
activated in subjects with diabetes, may contribute to 
modify the amount of connexins in atrial cardiomyocytes. 
4.4. Limitations 
Insofar patients in the present study had significant 
coronary artery disease and other co-morbidities, the 
present findings cannot be inferred to the overall spec-
trum of patients with diabetes. Particularly, pre-diabetic 
subjects with glucose intolerance were not studied and 
may have given further insights as to whether the ob-
served modifications may occur at an earlier stage. In 
addition, the size of the left atria, which represent atrial 
remodeling, was not documented in the present study. 
However, the effect of atrial remodeling, a possible 
confounding variable, was minimized by having selected 
a cohort of patients without significant valve disease, a 
normal ejection fraction, and in sinus rhythm.   
4.5. Conclusions 
In conclusion, we found an up-regulation of Cx40 pro-
tein content in right auricular appendix tissue from pa-
tients with type 2 diabetes. In light of other studies hav-
ing demonstrated a link between AF and Cx40 expres-
sion, it is possible that higher prevalence of AF in pa-
tients with diabetes is explained, at least partially, by 
differential expression of gap-junction proteins. Albeit 
further studies are still needed to understand the full im-
plication of Cx40 in AF, this study casts some light on a 
potentially important process occurring in individuals 
with diabetes, and may open-up new therapeutic and/or 
research vistas in order to treat and/or prevent AF in this 
at-risk population. 
5. ACKNOWLEDGEMENTS 
Drs Paul Poirier and Patrick Mathieu are research scholars from the 
Fonds de la Recherche en Santé du Québec. This work was supported 
by operating grants from the Quebec Heart Institute (Drs Paul Poirier 
and Pascal Daleau) and the Heart and Stroke Foundation of Quebec 
(Dr Pascal Daleau). 
 
REFERENCES 
[1]  Gu, K., Cowie, C.C. and Harris, M.I. (1999) Diabetes 
and decline in heart disease mortality in US adults. Jour-
nal of the American Medical association,  281, 1291- 
1297. P. Daleau et al. / HEALTH 2 (2010) 271-277 
Copyright  ©  2010  SciRes                                 Openly accessible at http://www.scirp.org/journal/HEALTH/ 
277
[2]  Grundy, S.M., Benjamin, I.J., Burke, G.L., Chait, A., 
Eckel, R.H., Howard, B.V., Mitch, W., Smith, S.C.Jr. 
and Sowers, J.R. (1999) Diabetes and cardiovascular 
disease: a statement for healthcare professionals from the 
American Heart Association. Circulation,  100, 1134- 
1146.  
[3]  Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Cur-
tis, A.B., Ellenbogen, K.A., Halperin, J.L., Le Heuzey, 
J.-Y., Kay, G.N., Lowe, J.E., Olsson, S.B., Prystowsky, 
E.N., Tamargo, J.L. and Wann, S. (2006) ACC/AHA 
Task Force Members, ESC Committee for Practice 
Guidelines: ACC/AHA/ESC 2006 guidelines for the 
management of patients with atrial fibrillation: a report 
of the American College of Cardiology/American Heart 
Association Task Force on Practice Guidelines and the 
European Society of Cardiology Committee for Practice 
Guidelines (Writing Committee to revise the 2001 guide-
lines for the management of patients with atrial fibrilla-
tion) developed in collaboration with the European Heart 
Rhythm Association and the Heart Rhythm Society. 
Circulation, 114, e257-e354. 
[4]  Benjamin, E.J., Levy, D., Vaziri, S.M., D'Agostino, R.B., 
Belanger, A.J. and Wolf, P.A. (1994) Independent risk 
factors for atrial fibrillation in a population-based cohort. 
The Framingham Heart Study. Journal of the American 
Medical association, 271, 1-11. 
[5]  Allessie, M.A., Boyden, P.A., Camm, A.J., Kléber, A.G., 
Lab, M.J., Legato, M.J., Rosen, M.R., Schwartz, P.J., 
Spooner, P.M., Van Wagoner, D.R. and Waldo, A.L. 
(2001) Pathophysiology and prevention of atrial fibrilla-
tion. Circulation, 103, 769-777.   
[6]  Poirier, P., Bogaty, P., Garneau, C., Marois, L. and Du-
mesnil, J.G. (2001) Diastolic dysfunction in normoten-
sive men with well-controlled type 2 diabetes: impor-
tance of maneuvers in echocardiographic screening for 
preclinical diabetic cardiomyopathy. Diabetes Care, 24, 
5-10. 
[7]  Poirier, P., Bogaty, P., Philippon, F., Garneau, C., Fortin, 
C. and Dumesnil, J.G. (2003) Preclinical diabetic car-
diomyopathy: relation of left ventricular diastolic dys-
function to cardiac autonomic neuropathy in men with 
uncomplicated well-controlled type 2 diabetes. Metabo-
lism, 52, 1056-1061. 
[8]  Magyar, J., Rusznak, Z., Szentesi, P., Szucs, G. and 
Kovacs, L. (1992) Action potentials and potassium cur-
rents in rat ventricular muscle during experimental dia-
betes. Journal of Molecular and Cellular Cardiology, 24, 
841-853. 
[9]  Nishiyama, A., Ishii, D.N., Backx,.P.H., Pulford, B.E., 
Birks, B.R. and Tamkun, M.M. (2001) Altered K
+ chan-
nel gene expression in diabetic rat ventricle: isoform 
switching between Kv4.2 and Kv1.4. American Journal 
of Physiology, 281, H1800-H1807. 
[10]  Gallego, M., Casis, E. and Izquierdo, M.J. (2000) Resto-
ration of cardiac transient outward potassium current by 
norepinephrine in diabetic rats. Pflügers Archives, 441, 
102-107. 
[11]  Xu, Z., Patel, K., Lou, M.F. and Rozanski, G.J. (2002) 
Up-regulation of K
+ channels in diabetic rat ventricular 
myocytes by insulin and glutathione. Cardiovascular 
Research, 53, 80-88. 
[12]  Pacher, P., Ungvari, Z., Nanasi, P.P. and Kecskeméti, V. 
(1999) Electrophysiological changes in rat ventricular 
and atrial myocardium at different stages of experimental 
diabetes. Acta Physiologica Scandinavica, 166, 7-13. 
[13]  Yang, Q., Kiyoshige, K., Fujimoto, T., Katayama, M., 
Fujino, K., Saito, K., Nakaya, Y. and Mori, H. (1990) 
Signal-averaging electrocardiogram in patients with dia-
betes mellitus. Japanese Heart Journal, 31, 25-33. 
[14]  Celiker, A., Akinci, A. and Özin, B. (1994) The sig-
nal-averaged electrocardiogram in diabetic children. In-
ternational Journal of Cardiology, 44, 271-274. 
[15]  Inoguchi, T., Ueda, F., Umeda, F., Yamashita, T. and 
Nawata, H. (1995) Inhibition of intercellular communi-
cation via gap junction in cultured aortic endothelial cells 
by elevated glucose and phorbol ester. Biochemical and 
Biophysical Research Communications, 208, 492-497. 
[16]  Kuroki, T., Inoguchi, T., Umeda, F., Ueda, F. and 
Nawata, H. (1998) High glucose induces alteration of 
gap junction permeability and phosphorylation of con-
nexin-43 in cultured aortic smooth muscle cells. Diabetes, 
47, 931-936. 
[17]  Inoguchi, T., Yu, H.Y., Imamura, M., Kakimoto, M., 
Kuroki, T., Maruyama, T. and Nawata, H. (2001) Altered 
gap junction activity in cardiovascular tissues of diabetes. 
Medical Electron Microscopy, 34, 86-91. 
[18]  Oku, H., Kodama, T., Sakagami, K., Puro, D.G. (2001) 
Diabetes-induced disruption of gap junction pathways 
within the retinal microvasculature. Investigative Oph-
thalmology and Visual Science, 42, 1915-1920. 
[19]  Poladia, D.P., Schanbacher, B., Wallace, L.J. and Bauer, 
J.A. (2005) Innervation and connexin isoform expression 
during diabetes-related bladder dysfunction: early struc-
tural vs. neuronal remodeling. Acta Diabetologica,  42, 
147-152. 
[20]  Stilli, D, Lagrasta, C., Berni, R., Bocchi, L., Savi, M., 
Delucchi, F., Graiani, G., Monica, M., Maestri, R., Ba-
ruffi, S., Rossi, S., Macchi, E., Musso, E. and Quaini, F. 
(2007) Preservation of ventricular performance at early 
stages of diabetic cardiomyopathy involves changes in 
myocyte size, number and intercellular coupling. Basic 
Research in Cardiology, 102, 488-499. 
[21]  Task Force of the European Society of Cardiology and 
the North American Society of Pacing and Electrophysi-
ology: Heart rate variability (1996) Standards of meas-
urement, physiological interpretation, and clinical use. 
European Heart Journal, 17, 354-381. 
[22]  Daleau, P., Boudriau, S., Michaud, M., Jolicoeur, C. and 
Kingma, J.G. Jr. (2001) Preconditioning in the absence 
or presence of sustained ischemia modulates myocardial 
Cx43 protein levels and gap junction distribution. Cana-
dian Journal of Physiology and Pharmacology, 79, 371- 
378. 
[23]  Sarrazin, J.-F., Comeau, G., Daleau, P., Kingma, J., 
Plante, I., Fournier, D. and Molin, F. (2007) Reduced in-
cidence of vagally-induced atrial fibrillation and expres-
sion levels of connexins by n-3 polyunsaturated fatty ac-
ids in dogs. Journal of the American College of Cardiol-
ogy, 50, 1505-1512. 
[24]  Lin, H., Ogawa, K., Imanaga, I. and Tribulova, N. (2006) 
Alterations of connexin 43 in the diabetic rat heart. Ad-
vance in Cardiology, 42, 243-254.   
[25]  Okruhlicova, L., Tribulova, N., Misejkova, M., Kucka, 
M., Stetka, R., Slezak, J. and Manoach, M. (2002) Gap P. Daleau et al. / HEALTH 2 (2010) 271-277 
Copyright  ©  2010  SciRes                                  http://www.scirp.org/journal/HEALTH/ Openly accessible at   
278 
junction remodeling is involved in the susceptibility of 
diabetic rats to hypokalemia-induced ventricular fibrilla-
tion. Acta Histochemica, 104, 387-391. 
[26]  Sheu, J.-J., Chang, L.-T., Chiang, C.-H., Sun, C.-K., 
Chang, N.-K., Youssef, A.A., Wu, C.-J., Lee, F.-Y. and 
Yip, H.-K. (2007) Impact of diabetes on cardiomyocyte 
apoptosis and connexin43 gap junction integrity. Role of 
pharmacological modulation. International Heart Jour-
nal, 48, 233-245. 
[27]  Brink, P.R., Valiunas, V., Wang, H.Z., Zhao, W., Davies, 
K. and Christ, G.J. (2006) Experimental diabetes alters 
connexin43 derived gap junction permeability in short- 
term cultures of rat corporeal vascular smooth muscle 
cells. Journal of Urology, 175, 381-386. 
[28]  Howarth, F., Nowotny, N., Zilahi, E., El Haj, M. and Lei, 
M. (2007) Altered expression of gap junction connexin 
proteins may partly underlie heart rhythm disturbances in 
the streptozotocin-induced diabetic rat heart. Molecular 
and Cellular Biochemistry, 305, 145-151. 
[29]  Wolfle, S.E., Schmidt, V.J., Hoepfl, B., Gebert, A., Al-
colea, S., Gros, D. and de Wit, C. (2007) Connexin45 
cannot replace the function of connexin40 in conducting 
endothelium-dependent dilations along arterioles. Circu-
lation Research, 101, 1292-1299. 
[30]  Östgren, C.J., Merlo, J., Råstam, L. and Lindblad, U. 
(2004) Atrial fibrillation and its association with type 2 
diabetes and hypertension in a Swedish community. 
Diabetes, Obesity and Metabolism, 6, 367-374. 
[31]  Movahed, M.-R., Hashemzadeh, M. and Jamal, M.M. 
(2005) Diabetes mellitus is a strong, independent risk for 
atrial fibrillation and flutter in addition to other cardio-
vascular disease. International Journal of Cardiology, 
105, 315-318. 
[32]  Dupont, E., Ko, Y.-S., Rothery, S., Coppen, S.R., Baghai, 
M., Haw, M. and Severs, N.J. (2001) The gap-junctional 
protein connexin 40 is elevated in patients susceptible to 
postoperative atrial fibrillation. Circulation,  103, 842- 
849. 
[33]  Polontchouk, L., Haefliger, J.-A., Ebelt, B., Schaefer, T., 
Stuhlmann, D., Mehlhorn, U. and Kuhn-Regnier, F. 
(2001) Effects of chronic atrial fibrillation on gap junc-
tion distribution in human and rat atria. Journal of the 
American College of Cardiology, 38, 883-891. 
[34]  Kostin, S., Klein, G., Szalay, Z., Hein, S., Bauer, E.P. 
and Schaper, J. (2002) Structural correlate of an atrial 
fibrillation in human patients. Cardiovascular Research, 
54, 361-379. 
[35]  Wetzel, U., Boldt, A., Lauschke, J., Weigl, J., Schirde-
wahn, P., Dorszewski, A., Doll, N., Hindricks, G., Dhein, 
S. and Kottkamp, H. (2005) Expression of connexins 40 
and 43 in human left atrium in atrial fibrillation of dif-
ferent aetiologies. Heart, 91, 166-170. 
[36]  Beauchamp, P., Yamada, K.A., Baertschi, A.J., Green, 
K., Kanter, E.M., Saffitz, J.E. and Kléber, A.G. (2006) 
Relative contributions of connexins 40 and 43 to atrial 
impulse propagation in synthetic strands of neonatal and 
fetal murine cardiomyocytes. Circulation Research, 99, 
1216-1224. 
[37]  Zhang, Y., Xiao, J., Lin, H., Luo, X., Wang, H., Bai, Y., 
Wang, J., Zhang, H., Yang, B. and Wang, Z. (2007) Ionic 
mechanisms underlying abnormal QT prolongation and 
the associated arrhythmias in diabetic rabbits: a role of 
rapid delayed rectifier K
+ current. Cellular Physiology 
and Biochemistry, 19, 225-238. 
[38]  Lengyel, C., Virag, L., Biro, T., Jost, N., Magyar, J., 
Biliczki, P., Kocsis, E., Skoumal, R., Nanasi, P.P., Toth, 
M., Kecskemeti, V., Papp, J.G. and Varro, A. (2007) 
Diabetes mellitus attenuates the repolarization reserve in 
mammalian heart. Cardiovascular Research,  73, 512- 
520. 
[39]  Casis, O., Gallego, M., Iriarte, M. and Sanchez-Chapula, 
J.A. (2000) Effects of diabetic cardiomyopathy on re-
gional electrophysiologic characteristics of rat ventricle. 
Diabetologia, 43, 101-109. 
[40]  Fernandez-Cobo, M., Gingalewski, C., Drujan, D. and 
De Maio, A. (1999) Downregulation of connexin 43 gene 
expression in rat heart during inflammation. The role of 
tumour necrosis factor. Cytokine, 11, 216-224.   
[41]  Fukuda, T., Ikejima, K., Hirose, M., Takei, Y., Watanabe, 
S. and Sato, N. (2000) Taurine preserves gap junctional 
intercellular communication in rat hepatocytes under 
oxidative stress. Journal of Gastroenterology, 35, 361- 
368. 
 
 